Search research articles
Contact Us
Filters
Showing results (231-240 of 258) with videos related to
Page
of 26
Sort By:
The Lancet. Infectious Diseases
|
June 10, 2018
Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial
Joshua Wolf, Tom G Connell, Kim J Allison, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 2015
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
M Spina, Z Nagy, J M Ribera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2014
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)
S Luminari, I Biasoli, A Versari, et al.
British Journal of Cancer
|
December 1, 2004
Classic Kaposi's sarcoma in Italy, 1985-1998
L Dal Maso, J Polesel, V Ascoli, et al.
Cancers
|
September 13, 2025
ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma
Jessica Gartrell, Fariba Navid, Xiaomeng Yuan, et al.
Thrombosis Research
|
May 11, 2016
PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL)
R M Santi, M Ceccarelli, G Catania, et al.
Pediatric Blood & Cancer
|
March 13, 2026
Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study
Daniel A Morgenstern, Giuseppe Barone, Nadege Corradini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies
Sara M Federico, Alberto S Pappo, Natasha Sahr, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging Agents
Jessica Gartrell, Marcia Mellado-Largarde, Michael R Clay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A
Wayne L Furman, Beth McCarville, Barry L Shulkin, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 258) with videos related to
Sort By:
Page
of 26
The Lancet. Infectious Diseases
|
June 10, 2018
Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial
Joshua Wolf, Tom G Connell, Kim J Allison, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 2015
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
M Spina, Z Nagy, J M Ribera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2014
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)
S Luminari, I Biasoli, A Versari, et al.
British Journal of Cancer
|
December 1, 2004
Classic Kaposi's sarcoma in Italy, 1985-1998
L Dal Maso, J Polesel, V Ascoli, et al.
Cancers
|
September 13, 2025
ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma
Jessica Gartrell, Fariba Navid, Xiaomeng Yuan, et al.
Thrombosis Research
|
May 11, 2016
PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL)
R M Santi, M Ceccarelli, G Catania, et al.
Pediatric Blood & Cancer
|
March 13, 2026
Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study
Daniel A Morgenstern, Giuseppe Barone, Nadege Corradini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies
Sara M Federico, Alberto S Pappo, Natasha Sahr, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging Agents
Jessica Gartrell, Marcia Mellado-Largarde, Michael R Clay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A
Wayne L Furman, Beth McCarville, Barry L Shulkin, et al.
Page
of 26